The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
Abstract
Frontotemporal dementia (FTD) is a devastating neurodegenerative disorder for which readily available biomarkers are needed to monitor disease progression and response to future therapies. Neurofilament light chain (NfL), a cytoskeletal protein, is elevated in the cerebrospinal fluid (CSF) of patients with FTD, correlating with disease severity.1 ,2 As CSF sampling is more invasive than venepuncture and requires higher subject compliance, we tested the hypothesis that NfL levels in FTD are elevated not only in CSF, but also in serum. NfL levels in FTD were also compared with those in amyotrophic lateral sclerosis (ALS).3 CSF and serum samples of a consecutive series of 41 FTD, 25 ALS and 46 healthy control subjects were collected from 2009 until 2014 (see online supplement 1: Methodological and statistical details, see online supplement 2: Subject characteristics). Only participants with normal CSF white cell counts (cell count 600 pg/mL, Innotest ELISA, Innogenetics, Belgium) were included. CSF and serum NfL concentrations were measured by a previously established electrochemiluminescence immunoassay.4 CSF levels of total tau (h-tau) were determined by a commercial ELISA (Innogenetics). ### Supplementary data [jnnp-2015-312972supp.pdf] NfL levels in CSF differed significantly between FTD, ALS and control subjects (F (2, 109)=88.36, p<0.001, one-way analysis of variance (ANOVA), calculated for log-transformed levels, figure 1A), also if corrected for age (F (2, 108)=88.66, p<0.001). Both patients with FTD (2557 pg/mL (median); 1760–3167, (IQR)) and patients with ALS (6658 pg/mL; (4205–10438)) showed significantly higher CSF NfL levels than controls (981 pg/mL; (777–1374)). NfL levels in ALS were significantly higher than in FTD (all p<0.001, two-sided Student's t tests, Bonferroni-corrected, effect sizes: FTD vs controls r=0.65, ALS vs controls r=0.85, ALS vs FTD r=0.59). Figure 1 (A) and (B) neurofilament light chain (NfL) levels in cerebrospinal fluid (CSF) and serum of frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blood NfL has already been implemented in the novel guidelines for differentiating FTD from non-degenerative primary psychiatric disorders [9, 25].”
In the citing paper
“In FTD patients it has been shown to be increased in CSF and serum, compared to cognitively healthy controls [23–26]”
In the citing paper
“In previous studies, NfL showed good discriminatory power, in CSF and serum, for the differentiation of FTD from controls (area under the curve (AUC) up to 0.88) [25, 28].”
Citations
Cites
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Gaiottino, J., Norgren, N., Dobson, R., Topping, J., Nissim, A., Malaspina, A., Bestwick, J. P., Monsch, A. U., Regeniter, A., Lindberg, R. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075091 · Cited by 486
Self-citationNeurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Steinacker, P., Feneberg, E., Weishaupt, J., Brettschneider, J., Tumani, H., Andersen, P. M., von Arnim, C. A. F., Böhm, S., Kassubek, J., Kubisch, C., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311387 · Cited by 317
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263
Scherling, C. S., Hall, T., Berisha, F., Klepac, K., Karydas, A., Coppola, G., Kramer, J. H., Rabinovici, G., Ahlijanian, M., Miller, B. L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24052 · Cited by 249
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Menke, R., Gray, E., Lu, C., Kühle, J., Talbot, K., Malaspina, A., & Turner, M. R. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.212 · Cited by 157
Cited by
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Self-citationNeurofilament light as a biomarker in traumatic brain injury
Shahim, P., Politis, A., van der Merwe, A., Moore, B., Chou, Y.-Y., Pham, D. L., Butman, J. A., Diaz-Arrastia, R., Gill, J. M., Brody, D. L., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009983 · Cited by 257
Imaging and fluid biomarkers in frontotemporal dementia
Meeter, L. H., Kaat, L. D., Rohrer, J. D., & van Swieten, J. C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.75 · Cited by 210
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Heller, C., Foiani, M. S., Moore, K., Convery, R., Bocchetta, M., Neason, M., Cash, D. M., Thomas, D., Greaves, C. V., Woollacott, I. O., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321954 · Cited by 182
Self-citationForgrave, L. M., Ma, M., Best, J. R., & DeMarco, M. L. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.08.009 · Cited by 177
Metadata
- Authors
- Wilke, C., Preische, O., Deuschle, C., Roeben, B., Apel, A., Barro, C., Maia, L., Maetzler, W., Kuhle, J., & Synofzik, M.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- University Hospital of Basel (CH)
- Corresponding author
- Synofzik, Matthis
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2016-05-17
- Volume
- 87
- Issue
- 11
- Pages
- 1270-1272
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W2404198556
- Cited by
- 79
- References
- 5
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 13 · 2021: 17 · 2020: 13 · 2019: 9 · 2018: 7 · 2017: 2 · 2016: 1
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neurofilament light chain, frontotemporal dementia, amyotrophic lateral sclerosis, serum biomarkers, cerebrospinal fluid biomarkers, neurodegeneration, tau protein, disease severity, neurofilament heavy chain, neurofilament phosphorylation
- MeSH terms
- Aged, Amyotrophic Lateral Sclerosis, Female, Humans, Male, Biomarkers, Neurofilament Proteins, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum. https://app.cochat.ai/papers/10.1136/jnnp-2015-312972
- The paper
- Wilke, C., Preische, O., Deuschle, C., Roeben, B., Apel, A., Barro, C., Maia, L., Maetzler, W., Kuhle, J., & Synofzik, M. (2016). Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2015-312972
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.